Precision Optics Corporation, Inc. (POCI) stock
POCINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3033% below fair value
$4.17−0.80 (-16.10%)
Close on Nov 17, 2026Market cap $45.76MP/E –Yield –
Precision Optics r&d expenses
Research and development expenses are spending on new products and technology.
Precision Optics's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.03M, down 10.8% year over year. For fiscal 2026 it was $1.03M, down 10.8% from the year before. Over ten years it grew 8.0% a year on average. The highest annual figure on record is $1.16M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.03M | -10.8% |
| FY2025 | Jun 30, 2025 | $1.16M | +17.9% |
| FY2024 | Jun 30, 2024 | $981.78K | -1.1% |
| FY2023 | Jun 30, 2023 | $992.38K | +48.9% |
| FY2022 | Jun 30, 2022 | $666.48K | +6.8% |
| FY2021 | Jun 30, 2021 | $624.25K | -29.6% |
| FY2020 | Jun 30, 2020 | $886.13K | +75.4% |
| FY2019 | Jun 30, 2019 | $505.30K | +10.7% |
| FY2018 | Jun 30, 2018 | $456.38K | -1.7% |
| FY2017 | Jun 30, 2017 | $464.16K | -2.9% |
| FY2016 | Jun 30, 2016 | $478.27K | -3.0% |
| FY2015 | Jun 30, 2015 | $492.94K | +4.6% |
| FY2014 | Jun 30, 2014 | $471.11K | -25.3% |
| FY2013 | Jun 30, 2013 | $630.29K | -5.2% |
| FY2012 | Jun 30, 2012 | $664.70K | -19.4% |
| FY2011 | Jun 30, 2011 | $825.03K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $204.42K | -10.5% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $267.32K | +26.5% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $249.57K | -21.5% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $311.84K | -22.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $228.32K | -35.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $211.24K | +9.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $317.75K | +43.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $400.66K | +88.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $354.52K | +6.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $192.77K | -6.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $221.73K | +42.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $212.76K | -13.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $331.86K | +42.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $206.38K | -4.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $155.26K | +37.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $245.48K | +133.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $233.23K | +29.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $214.90K | +47.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $113.16K | -22.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $105.19K | -30.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $180.64K | -2.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $146.06K | -54.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $145.97K | -36.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $151.58K | -0.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $185.52K | +17.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $319.88K | +163.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $228.58K | +82.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $152.15K | +50.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $157.45K | +29.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $121.64K | -3.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $125.41K | +18.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $100.80K | -17.6% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $121.55K | +2.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $126.37K | +8.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $105.64K | +4.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $122.31K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $119.22K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $116.99K | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $101.07K | – |
See a number that looks wrong?